Bill Summary
This legislation amends the Public Health Service Act by enhancing the requirements for state plans related to Substance Use Prevention, Treatment, and Recovery Services block grants. Specifically, it mandates that states provide additional information in their plans regarding medication-assisted treatment (MAT) for substance use disorders. The new requirements include detailing:
1. The types of drugs available for MAT within the state's healthcare system.
2. The specific MAT programs or protocols implemented to prevent drug diversion and misuse.
3. Data on any instances of misuse associated with MAT, particularly cases where these medications are combined with other prescriptions.
4. Information on drug screening protocols used in the state's healthcare system, especially for patients undergoing MAT.
The goal of this amendment is to improve transparency and accountability in state substance use treatment programs, facilitating better oversight and potentially leading to more effective prevention and recovery strategies.
Possible Impacts
Here are three examples of how the legislation described in the bill could affect people:
1. **Improved Access to Treatment Information**: By requiring states to provide detailed information about the types of drugs available for medication-assisted treatment (MAT), individuals seeking help for substance use disorders will have better access to information about their treatment options. This can empower patients to make informed decisions about their care and potentially lead to higher engagement in treatment programs.
2. **Enhanced Monitoring of Treatment Protocols**: The legislation mandates that states outline their protocols for diversion and misuse prevention related to medication-assisted treatment. This can lead to the implementation of more effective monitoring practices, reducing the likelihood of misuse and ensuring that individuals receiving treatment are doing so safely. As a result, patients may experience a more secure treatment environment with less risk of drug diversion.
3. **Data-Driven Policy Making**: The requirement for states to report data on drug misuse associated with medication-assisted treatment and drug screening protocols can provide valuable insights into the effectiveness and safety of MAT programs. This data can help policymakers identify trends, allocate resources more effectively, and develop targeted interventions, ultimately leading to improved outcomes for individuals struggling with substance use disorders. As a result, communities may see a decrease in drug-related incidents and an increase in successful recovery rates.
[Congressional Bills 119th Congress]
[From the U.S. Government Publishing Office]
[H.R. 5630 Introduced in House (IH)]
<DOC>
119th CONGRESS
1st Session
H. R. 5630
To amend the Public Health Service Act to require additional
information in State plans for Substance Use Prevention, Treatment, and
Recovery Services block grants.
_______________________________________________________________________
IN THE HOUSE OF REPRESENTATIVES
September 30, 2025
Mrs. Houchin introduced the following bill; which was referred to the
Committee on Energy and Commerce
_______________________________________________________________________
A BILL
To amend the Public Health Service Act to require additional
information in State plans for Substance Use Prevention, Treatment, and
Recovery Services block grants.
Be it enacted by the Senate and House of Representatives of the
United States of America in Congress assembled,
SECTION 1. STATE PLAN REQUIREMENTS FOR SUBSTANCE USE PREVENTION,
TREATMENT, AND RECOVERY SERVICES BLOCK GRANTS.
Section 1932(b)(1)(A) of the Public Health Service Act (42 U.S.C.
300x-32(b)(1)(A)) is amended--
(1) in clause (ix), by striking ``and'' at the end;
(2) in clause (x), by striking the period at the end and
inserting ``; and''; and
(3) by adding at the end the following:
``(xi) describes--
``(I) the types of drugs available
for the purpose of medication-assisted
treatment within the State's system of
care;
``(II) the State's medication-
assisted treatment programs or
protocols used for diversion and misuse
prevention and enforcement;
``(III) the State's data on any
misuse of drugs used for medication-
assisted treatment, including instances
of medication-assisted treatment being
mixed with other prescription drugs;
and
``(IV) the State's data on any drug
screening protocols within the State's
system of care, including any specific
protocols for drug screening patients
who receive medication-assisted
treatment.''.
<all>